SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-24-008994
Filing Date
2024-02-01
Accepted
2024-02-01 16:15:02
Documents
1
Group Members
AISLING CAPITAL PARTNERS V LLCAISLING CAPITAL PARTNERS V, LPDR. ANDREW SCHIFFSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea192609-13gaisling5_calci.htm SC 13G 140659
  Complete submission text file 0001213900-24-008994.txt   142674
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

IRS No.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91725 | Film No.: 24587103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 212-651-6380
Aisling Capital V, LP (Filed by) CIK: 0001776233 (see all company filings)

IRS No.: 833267456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G